AU2972199A - Apoptosis inducing molecule ii and methods of use - Google Patents
Apoptosis inducing molecule ii and methods of useInfo
- Publication number
- AU2972199A AU2972199A AU29721/99A AU2972199A AU2972199A AU 2972199 A AU2972199 A AU 2972199A AU 29721/99 A AU29721/99 A AU 29721/99A AU 2972199 A AU2972199 A AU 2972199A AU 2972199 A AU2972199 A AU 2972199A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- apoptosis inducing
- inducing molecule
- molecule
- apoptosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000006907 apoptotic process Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7540998P | 1998-02-20 | 1998-02-20 | |
US60075409 | 1998-02-20 | ||
US09/027,287 US6479254B2 (en) | 1996-03-22 | 1998-02-20 | Apoptosis inducing molecule II |
US09027287 | 1998-02-20 | ||
PCT/US1999/003703 WO1999042584A1 (en) | 1998-02-20 | 1999-02-19 | Apoptosis inducing molecule ii and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2972199A true AU2972199A (en) | 1999-09-06 |
Family
ID=26702277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU29721/99A Abandoned AU2972199A (en) | 1998-02-20 | 1999-02-19 | Apoptosis inducing molecule ii and methods of use |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1054968A1 (en) |
JP (1) | JP2002504333A (en) |
AU (1) | AU2972199A (en) |
CA (1) | CA2321186A1 (en) |
WO (1) | WO1999042584A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6495520B2 (en) | 1996-03-22 | 2002-12-17 | Human Genome Sciences, Inc. | Apoptosis Inducing Molecule II and methods of use |
US6635743B1 (en) | 1996-03-22 | 2003-10-21 | Human Genome Sciences, Inc. | Apoptosis inducing molecule II and methods of use |
US7964190B2 (en) | 1996-03-22 | 2011-06-21 | Human Genome Sciences, Inc. | Methods and compositions for decreasing T-cell activity |
US6479254B2 (en) | 1996-03-22 | 2002-11-12 | Human Genome Sciences, Inc. | Apoptosis inducing molecule II |
US6140467A (en) * | 1997-07-07 | 2000-10-31 | La Jolla Institute For Allergy And Immunology | Ligand for herpes simplex virus entry mediator and methods of use |
US7118742B2 (en) | 1997-07-07 | 2006-10-10 | La Jolla Institute For Allergy And Immunology | Ligand for herpes simplex virus entry mediator and methods of use |
US6998108B1 (en) | 1997-07-07 | 2006-02-14 | La Jolla Institute For Allergy And Immunology | Antibodies to p30 polypeptides and methods making and using same |
JP2003528030A (en) * | 1999-03-11 | 2003-09-24 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | Apoptosis-inducing molecule II |
WO2001079496A2 (en) * | 2000-03-13 | 2001-10-25 | La Jolla Institute For Allergy And Immunology | Ligand for herpes simplex virus entry mediator and methods of use |
ES2352742T3 (en) * | 2000-04-12 | 2011-02-22 | La Jolla Institute For Allergy And Immunology | BINDING FOR THE SIMPLE HERPES VIRUS INPUT MEDIATOR AND USE PROCEDURES. |
EP1364653A4 (en) * | 2001-02-23 | 2005-01-26 | Takeda Pharmaceutical | Casoase 3 inhibitors |
WO2002066049A1 (en) * | 2001-02-23 | 2002-08-29 | Takeda Chemical Industries, Ltd. | Agents for plasmic change |
ES2643687T3 (en) | 2006-08-28 | 2017-11-23 | Kyowa Hakko Kirin Co., Ltd. | HLIGHT antagonist-specific human monoclonal antibodies |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100497017B1 (en) * | 1996-03-22 | 2005-11-29 | 휴먼 게놈 사이언시즈, 인코포레이티드 | Highly induced molecule II |
DE69730607T2 (en) * | 1996-07-19 | 2005-01-27 | Takeda Chemical Industries, Ltd. | FAS LIGAND SIMILAR PROTEIN, ITS MANUFACTURE AND USE |
US6346388B1 (en) * | 1997-08-13 | 2002-02-12 | Smithkline Beecham Corporation | Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
WO1999011662A1 (en) * | 1997-09-05 | 1999-03-11 | Millennium Biotherapeutics, Inc. | Novel molecules of the tnfr-ligand-related protein family and uses thereof |
-
1999
- 1999-02-19 EP EP99910970A patent/EP1054968A1/en not_active Withdrawn
- 1999-02-19 WO PCT/US1999/003703 patent/WO1999042584A1/en not_active Application Discontinuation
- 1999-02-19 JP JP2000532524A patent/JP2002504333A/en not_active Withdrawn
- 1999-02-19 AU AU29721/99A patent/AU2972199A/en not_active Abandoned
- 1999-02-19 CA CA002321186A patent/CA2321186A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2321186A1 (en) | 1999-08-26 |
JP2002504333A (en) | 2002-02-12 |
EP1054968A1 (en) | 2000-11-29 |
WO1999042584A9 (en) | 1999-11-18 |
WO1999042584A1 (en) | 1999-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5711196A (en) | Apoptosis inducing molecule i | |
AU4520801A (en) | Novel substituted phenanthridinones and methods of use thereof | |
AU7812998A (en) | Versatile stereotactic device and methods of use | |
EP1018987A4 (en) | Neocartilage and methods of use | |
AU1616499A (en) | Chemokine variants and methods of use | |
AU8967998A (en) | Antibiotic-ligand conjugates and methods of use thereof | |
AU3623700A (en) | Apoptosis inducing molecule ii and methods of use | |
AU2972199A (en) | Apoptosis inducing molecule ii and methods of use | |
AU3374699A (en) | Methods of preparing and using electrostatically treated fluids | |
AU5923998A (en) | 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same | |
AU3241895A (en) | Apoptosis related protein bcl-y, and methods of use thereof | |
AU3118297A (en) | Sok-1 and methods of use | |
AU1451200A (en) | Dual reporter system and methods of use therefor | |
AU1126000A (en) | Proliferation and apoptosis related proteins | |
AU2587399A (en) | Human transport-associated molecules | |
AU6412599A (en) | Oxybutynin formulations and methods of use | |
AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
AU6582698A (en) | Therapeutic uses of grip and grip-related molecules | |
AU5446499A (en) | Apoptosis inducing agents | |
IL134210A0 (en) | Use of transcription factor brn-3a | |
AU5131699A (en) | Cryogranulation of activated protein c | |
AU4629399A (en) | Substituted piperazones and their therapeutic uses | |
AU2588000A (en) | Novel adhesion molecule and methods of use | |
AU2584699A (en) | Immediate early genes and methods of use therefor | |
AU6084598A (en) | Antibiotic-ligand conjugates and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |